T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gen Digital
GEN
|
+$2.03B |
| 2 |
DuPont de Nemours
DD
|
+$1.83B |
| 3 |
Crown Castle
CCI
|
+$1.58B |
| 4 |
Microsoft
MSFT
|
+$1.48B |
| 5 |
TransUnion
TRU
|
+$781M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
DD
Du Pont De Nemours E I
DD
|
+$1.72B |
| 2 |
Starbucks
SBUX
|
+$1.59B |
| 3 |
WBA
Walgreens Boots Alliance
WBA
|
+$1.3B |
| 4 |
Lowe's Companies
LOW
|
+$1.13B |
| 5 |
Philip Morris
PM
|
+$1.01B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17.59% |
| 2 | Financials | 16.53% |
| 3 | Technology | 15% |
| 4 | Consumer Discretionary | 13.37% |
| 5 | Industrials | 9.85% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1251
John B. Sanfilippo & Son
JBSS
$989M
| $16M | ﹤0.01% |
237,351
+13,196
| +6% | +$846K |
|
|
EXPR
1252
DELISTED
Express, Inc.
EXPR
| $16M | ﹤0.01% |
118,029
+51,804
| +78% | +$6.54M |
|
|
LM
1253
DELISTED
Legg Mason, Inc.
LM
| $15.9M | ﹤0.01% |
405,649
-315,042
| -44% | -$12.1M |
|
1254
Globe Life
GL
$13.8B
| $15.9M | ﹤0.01% |
198,948
+527
| +0.3% | +$41.1K |
|
|
AXE
1255
DELISTED
Anixter International Inc
AXE
| $15.9M | ﹤0.01% |
186,874
+9,423
| +5% | +$724K |
|
1256
Qorvo
QRVO
$8.67B
| $15.8M | ﹤0.01% |
224,158
+3,388
| +2% | +$236K |
|
1257
Leidos
LDOS
$17.6B
| $15.6M | ﹤0.01% |
263,946
+219,400
| +493% | +$12.2M |
|
1258
Akamai
AKAM
$18B
| $15.5M | ﹤0.01% |
318,759
-6,591
| -2% | -$315K |
|
1259
Avery Dennison
AVY
$13.6B
| $15.4M | ﹤0.01% |
156,428
-1,453
| -0.9% | -$137K |
|
|
CBIO
1260
Crescent Biopharma
CBIO
$610M
| $15.4M | ﹤0.01% |
10,989
-2,639
| -19% | -$3.1M |
|
1261
Goodyear
GT
$1.78B
| $15.2M | ﹤0.01% |
458,394
+873
| +0.2% | +$28.4K |
|
1262
International Seaways
INSW
$4.58B
| $15.2M | ﹤0.01% |
772,982
+500
| +0.1% | +$10.2K |
|
|
BFX
1263
DELISTED
BowFlex Inc.
BFX
| $15.1M | ﹤0.01% |
894,744
-9,200
| -1% | -$159K |
|
|
PDCE
1264
DELISTED
PDC Energy, Inc.
PDCE
| $15.1M | ﹤0.01% |
307,444
+14,582
| +5% | +$627K |
|
1265
Nu Skin
NUS
$236M
| $15M | ﹤0.01% |
244,751
+15,177
| +7% | +$932K |
|
|
AKAO
1266
DELISTED
Achaogen Inc
AKAO
| $15M | ﹤0.01% |
938,876
-78,043
| -8% | -$1.49M |
|
|
MNTA
1267
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
| $14.9M | ﹤0.01% |
804,286
-2,800
| -0.3% | -$46.8K |
|
1268
Zai Lab
ZLAB
$2.86B
| $14.9M | ﹤0.01% |
+551,000
| New | +$15.4M |
|
1269
Douglas Dynamics
PLOW
$981M
| $14.8M | ﹤0.01% |
376,214
+206,879
| +122% | +$7.06M |
|
1270
Barings BDC
BBDC
$987M
| $14.8M | ﹤0.01% |
1,033,097
-9,400
| -0.9% | -$142K |
|
|
SNI
1271
DELISTED
Scripps Networks Interactive, Inc Common Class A
SNI
| $14.6M | ﹤0.01% |
170,379
-1,477
| -0.9% | -$122K |
|
|
SCG
1272
DELISTED
Scana
SCG
| $14.6M | ﹤0.01% |
301,704
-10,609
| -3% | -$651K |
|
|
BEAT
1273
DELISTED
BioTelemetry, Inc.
BEAT
| $14.6M | ﹤0.01% |
441,828
+178,727
| +68% | +$6.19M |
|
|
TPGE.U
1274
DELISTED
TPG Pace Energy Holdings Corp.
TPGE.U
| $14.4M | ﹤0.01% |
1,411,287
+8,773
| +0.6% | +$90.1K |
|
|
ESL
1275
DELISTED
Esterline Technologies
ESL
| $14.4M | ﹤0.01% |
159,876
+19,568
| +14% | +$1.76M |
|
Similar funds
T. Rowe Price Associates's Q3 2017 Portfolio in Review
As of Q3 2017, T. Rowe Price Associates held 2,642 positions worth $585B, up 5.3% from $556B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
T. Rowe Price Associates's Q3 2017 filing shows 88 new, 1,025 increased, 900 reduced and 73 closed positions. Its largest new stake was Brighthouse Financial: 4,532,679 shares worth $276M. The largest sale was Du Pont De Nemours E I, an estimated $1.72B.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, down from 18% a quarter earlier, followed by Financials and Technology.
- T. Rowe Price Associates's largest Q3 2017 buy was Brighthouse Financial: 4,532,679 shares worth $276M.
- T. Rowe Price Associates added most to Gen Digital in Q3 2017, an estimated $2.03B increase.
- T. Rowe Price Associates's biggest Q3 2017 reduction was Starbucks, cutting an estimated $1.59B.
- T. Rowe Price Associates fully exited Du Pont De Nemours E I in Q3 2017, selling an estimated $1.72B.
- T. Rowe Price Associates's ten largest holdings make up 18% of its $585B portfolio in Q3 2017.
- T. Rowe Price Associates opened 88 new positions and closed 73 in Q3 2017.
- T. Rowe Price Associates's portfolio value rose 5.3% quarter-over-quarter to $585B.
Based on T. Rowe Price Associates's 13F filing for Q3 2017, filed 14 Nov 2017.